Home

Dana G Mead Jr.

CIK 1222358 · last filed 2026-06-09

Dana G Mead Jr. is a corporate insider who has filed 45 SEC Form 4 insider transactions across 6 companies since 2014. The most recent filing, for LUNG, was dated Jun 9, 2026. Across all open-market trades the lifetime net is +$1.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.31M

Companies

6

Total Filings

45

Lifetime Open-Market Net

$1.13M

Filer Profile

Reported Address
2750 SAND HILL ROAD
MENLO PARK, CA 94025
Formerly Known As
MEAD DANA G JR (2003–2005)
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LUNG Director 143,790 $1.85 $266.0K $500.0K 8 2026-06-09
MOBI Director 7,000 $10.01 $70.1K $105.0K 1 2026-05-11
INSP Director 26,213 $73.00 $1.91M $320.0K 9 2026-05-04
Inari Medical, Inc. (NARI) Delisted Director 0 $79.97 $0 $0 6 2025-02-19
Intersect ENT, Inc. (XENT) Delisted Director 1,751,828 $28.24 $49.47M $99.9K 14 2022-05-16
TDOC Director 10,202 $6.16 $62.8K $106.5K 7 2016-08-10

Recent Filings

45 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-09 LUNG Grant (A) +40,000 $0 EDGAR
2026-05-11 MOBI Mixed +7,000 $105.0K EDGAR
2026-05-04 INSP Grant (A) +3,562 $0 EDGAR
2025-06-04 LUNG Grant (A) +37,153 $0 EDGAR
2025-05-05 INSP Grant (A) +1,266 $0 EDGAR
2025-02-19 Inari Medical, Inc. (NARI) Delisted U −11,148 $0 EDGAR
2024-06-05 LUNG Grant (A) +15,216 $0 EDGAR
2024-05-31 Inari Medical, Inc. (NARI) Delisted Grant (A) +4,126 $175.0K EDGAR
2024-05-06 INSP Grant (A) +716 $0 EDGAR
2024-04-26 Inari Medical, Inc. (NARI) Delisted Grant (A) +4,126 $175.0K EDGAR
Showing 1–10 of 45
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.